(1)
Kumar, V.; Panda, B. K. CAN COST OF PHARMACOLOGICAL THROMBOLYTIC THERAPY BE A MEDICATION MANAGEMENT STRATEGY FOR ACUTE CORONARY SYNDROME?. Asian J Pharm Clin Res 2017, 10, 363-366.